We are live on ! Find out more
VIGL

Vigil Neuroscience

Delisted

VIGL was delisted on the 4th of August, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
AVLSA
1
Atlas Venture Life Science Advisors
Massachusetts
$19.9M
NV
2
Northpond Ventures
Maryland
$14.4M
Citadel Advisors
3
Citadel Advisors
Florida
$7.39M +$12.2K +3,909 +0.2%
BI
4
BVF Inc
California
$6.18M
AG
5
Artal Group
Luxembourg
$6.18M
SFM
6
Sphera Funds Management
Israel
$5.9M +$3.73M +1,195,294 +223%
DTC
7
Deep Track Capital
Connecticut
$5.44M
6CM
8
683 Capital Management
New York
$3.39M +$3.11M +994,900 New
DM
9
Deerfield Management
New York
$3.34M -$603K -193,212 -16%
Vanguard Group
10
Vanguard Group
Pennsylvania
$3.05M +$297K +95,276 +12%
BlackRock
11
BlackRock
New York
$2.99M -$131K -42,100 -5%
PBPIA
12
Pivotal bioVenture Partners Investment Advisor
California
$1.91M
RSCM
13
Rock Springs Capital Management
Maryland
$1.61M
O
14
OrbiMed
New York
$1.53M
Geode Capital Management
15
Geode Capital Management
Massachusetts
$1.14M +$58.4K +18,704 +6%
ACH
16
ArrowMark Colorado Holdings
Colorado
$987K
State Street
17
State Street
Massachusetts
$975K +$8.65K +2,772 +1%
Ensign Peak Advisors
18
Ensign Peak Advisors
Utah
$780K
Northern Trust
19
Northern Trust
Illinois
$473K -$8.37K -2,681 -2%
Barclays
20
Barclays
United Kingdom
$385K -$33.6K -10,759 -9%
DCM
21
DAFNA Capital Management
California
$245K
Bank of Montreal
22
Bank of Montreal
Ontario, Canada
$235K +$104K +33,368 New
Citigroup
23
Citigroup
New York
$230K +$2.05K +658 +1%
Renaissance Technologies
24
Renaissance Technologies
New York
$204K +$187K +59,964 New
BCM
25
Bridgeway Capital Management
Texas
$198K -$234K -75,000 -56%